Literature DB >> 22493227

Transition states of native and drug-resistant HIV-1 protease are the same.

D Randal Kipp1, Jennifer S Hirschi, Aya Wakata, Harris Goldstein, Vern L Schramm.   

Abstract

HIV-1 protease is an important target for the treatment of HIV/AIDS. However, drug resistance is a persistent problem and new inhibitors are needed. An approach toward understanding enzyme chemistry, the basis of drug resistance, and the design of powerful inhibitors is to establish the structure of enzymatic transition states. Enzymatic transition structures can be established by matching experimental kinetic isotope effects (KIEs) with theoretical predictions. However, the HIV-1 protease transition state has not been previously resolved using these methods. We have measured primary (14)C and (15)N KIEs and secondary (3)H and (18)O KIEs for native and multidrug-resistant HIV-1 protease (I84V). We observed (14)C KIEs ((14)V/K) of 1.029 ± 0.003 and 1.025 ± 0.005, (15)N KIEs ((15)V/K) of 0.987 ± 0.004 and 0.989 ± 0.003, (18)O KIEs ((18)V/K) of 0.999 ± 0.003 and 0.993 ± 0.003, and (3)H KIEs ((3)V/K) KIEs of 0.968 ± 0.001 and 0.976 ± 0.001 for the native and I84V enzyme, respectively. The chemical reaction involves nucleophilic water attack at the carbonyl carbon, proton transfer to the amide nitrogen leaving group, and C-N bond cleavage. A transition structure consistent with the KIE values involves proton transfer from the active site Asp-125 (1.32 Å) with partial hydrogen bond formation to the accepting nitrogen (1.20 Å) and partial bond loss from the carbonyl carbon to the amide leaving group (1.52 Å). The KIEs measured for the native and I84V enzyme indicate nearly identical transition states, implying that a true transition-state analogue should be effective against both enzymes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493227      PMCID: PMC3340095          DOI: 10.1073/pnas.1202808109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Enzymatic transition-state analysis and transition-state analogs.

Authors:  V L Schramm
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  A combined QM/MM approach to protein--ligand interactions: polarization effects of the HIV-1 protease on selected high affinity inhibitors.

Authors:  Christian Hensen; Johannes C Hermann; Kwangho Nam; Shuhua Ma; Jiali Gao; Hans-Dieter Höltje
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

3.  Ionization states of the catalytic residues in HIV-1 protease.

Authors:  R Smith; I M Brereton; R Y Chai; S B Kent
Journal:  Nat Struct Biol       Date:  1996-11

4.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

Authors:  A Wlodawer; M Miller; M Jaskólski; B K Sathyanarayana; E Baldwin; I T Weber; L M Selk; L Clawson; J Schneider; S B Kent
Journal:  Science       Date:  1989-08-11       Impact factor: 47.728

5.  Kinetic, stability, and structural changes in high-resolution crystal structures of HIV-1 protease with drug-resistant mutations L24I, I50V, and G73S.

Authors:  Fengling Liu; Peter I Boross; Yuan-Fang Wang; Jozsef Tozser; John M Louis; Robert W Harrison; Irene T Weber
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

6.  Observation of a tetrahedral reaction intermediate in the HIV-1 protease-substrate complex.

Authors:  Mukesh Kumar; Vishal Prashar; Smita Mahale; Madhusoodan V Hosur
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 7.  Use of steady state kinetic methods to elucidate the kinetic and chemical mechanisms of retroviral proteases.

Authors:  T D Meek; E J Rodriguez; T S Angeles
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

8.  Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.

Authors:  Y X Wang; D I Freedberg; T Yamazaki; P T Wingfield; S J Stahl; J D Kaufman; Y Kiso; D A Torchia
Journal:  Biochemistry       Date:  1996-08-06       Impact factor: 3.162

9.  Rate-determining steps in HIV-1 protease catalysis. The hydrolysis of the most specific substrate.

Authors:  Z Szeltner; L Polgár
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

10.  Transition-state structure of human 5'-methylthioadenosine phosphorylase.

Authors:  Vipender Singh; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2006-11-15       Impact factor: 15.419

View more
  10 in total

1.  Dynamic and Electrostatic Effects on the Reaction Catalyzed by HIV-1 Protease.

Authors:  Agnieszka Krzemińska; Vicent Moliner; Katarzyna Świderek
Journal:  J Am Chem Soc       Date:  2016-12-09       Impact factor: 15.419

Review 2.  Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.

Authors:  Rodrigo G Ducati; Hilda A Namanja-Magliano; Vern L Schramm
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

3.  Correlation of chemical shifts predicted by molecular dynamics simulations for partially disordered proteins.

Authors:  Jerome M Karp; Ertan Eryilmaz; Ertan Erylimaz; David Cowburn
Journal:  J Biomol NMR       Date:  2014-11-22       Impact factor: 2.835

Review 4.  Transition States, analogues, and drug development.

Authors:  Vern L Schramm
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

5.  QM/MM Analysis of Transition States and Transition State Analogues in Metalloenzymes.

Authors:  D Roston; Q Cui
Journal:  Methods Enzymol       Date:  2016-07-01       Impact factor: 1.600

6.  Capturing the reaction pathway in near-atomic-resolution crystal structures of HIV-1 protease.

Authors:  Chen-Hsiang Shen; Yunfeng Tie; Xiaxia Yu; Yuan-Fang Wang; Andrey Y Kovalevsky; Robert W Harrison; Irene T Weber
Journal:  Biochemistry       Date:  2012-09-21       Impact factor: 3.162

7.  Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease.

Authors:  Ian Mitchelle S de Vera; Adam N Smith; Maria Cristina A Dancel; Xi Huang; Ben M Dunn; Gail E Fanucci
Journal:  Biochemistry       Date:  2013-05-01       Impact factor: 3.162

Review 8.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

9.  Visualizing Tetrahedral Oxyanion Bound in HIV-1 Protease Using Neutrons: Implications for the Catalytic Mechanism and Drug Design.

Authors:  Mukesh Kumar; Kalyaneswar Mandal; Matthew P Blakeley; Troy Wymore; Stephen B H Kent; John M Louis; Amit Das; Andrey Kovalevsky
Journal:  ACS Omega       Date:  2020-05-14

Review 10.  Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies.

Authors:  Brigitta Elsässer; Peter Goettig
Journal:  Int J Mol Sci       Date:  2021-03-22       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.